Altern Ther Health Med. 2023 Nov;29(8):506-511.
The purpose of this study is to analyze the clinical prognosis of idiopathic sudden sensorineural hearing loss in patients with total deafness, and to check the differences in different age groups and hearing loss degrees.
From February 2021 to January 2022, 75 patients with complete deafness and idiopathic sudden sensorineural hearing loss were analyzed retrospectively. According to different age stages, they were divided into five groups: children's group, youth group, middle-aged group, pre-senile group and elderly group, with 15 cases in each group. According to the degree of initial hearing loss, the patients were divided into three groups: 81-89dbhl (81dB Hearing Loss Group), 90-99 dbhl (90 dB group) and ≥100 dbhl (100 dB group), with 25 cases in each group. All patients were given routine comprehensive treatment. Analyze the general situation of each group, the relationship between each age group and the degree of hearing loss, the relationship between each age group and the curative effect, the relationship between each hearing loss group and the curative effect, and the relationship between each age group and the vertigo. To analyze the relationship between hearing loss group and curative effect.
(1) Patients with idiopathic sudden sensorineural hearing loss had more unilateral hearing loss than bilateral hearing loss, P < .05. (2) The clinical therapeutic effect of (3) 81 dB group was the highest, followed by 90 dB group. Compared with the total effective rate data of 100 dB group, P < .05. (4) The clinical efficacy of patients with complete deafness and idiopathic sudden sensorineural hearing loss without vertigo in all ages was higher than that of patients with vertigo (P < .05). The clinical effect of hearing loss in patients without vertigo was higher than that in patients with vertigo (P < .05).
The patients with total deafness and Idiopathic sudden sensorineural hearing loss are mainly young and middle-aged people aged 14-59, with 100 dB as the boundary, and important information for predicting clinical prognosis and curative effect can be obtained.It is also suggested that for young and middle-aged patients aged 14-59, the focus of treatment may be more on restoring hearing function so that they can continue their work, study and social activities. For patients with mild hearing loss, the goal of treatment may be to maintain the existing hearing level or slow down the process of hearing loss. For patients with severe hearing loss, the focus of treatment may be to restore hearing function to improve their quality of life.
本研究旨在分析全聋伴特发性突发性聋患者的临床预后，并检查不同年龄组和听力损失程度之间的差异。
回顾性分析 2021 年 2 月至 2022 年 1 月间 75 例全聋伴特发性突发性聋患者，根据不同年龄段分为儿童组、青年组、中年组、老年前期组和老年组，每组 15 例。根据初始听力损失程度分为 81-89dBHL（81dB 听力损失组）、90-99dBHL（90dB 组）和≥100dBHL（100dB 组）三组，每组 25 例。所有患者均给予常规综合治疗。分析各组一般情况、各年龄组与听力损失程度的关系、各年龄组与疗效的关系、各听力损失组与疗效的关系、各年龄组与眩晕的关系。分析听力损失组与疗效的关系。
（1）特发性突发性聋患者单侧听力损失多于双侧听力损失，P<0.05。（2）（3）81dB 组临床疗效最高，90dB 组次之，与 100dB 组总有效率数据比较，P<0.05。（4）各年龄段全聋伴特发性突发性聋无眩晕患者的临床疗效均高于有眩晕患者（P<0.05）。无眩晕患者听力损失的临床疗效高于有眩晕患者（P<0.05）。
全聋伴特发性突发性聋患者主要为 14-59 岁的青年和中年人，以 100dB 为界，可获得预测临床预后和疗效的重要信息。建议对 14-59 岁的中青年患者，治疗重点可能更多地放在恢复听力功能上，使他们能够继续工作、学习和社会活动。对于轻度听力损失的患者，治疗目标可能是维持现有的听力水平或减缓听力损失的进程。对于重度听力损失的患者，治疗重点可能是恢复听力功能，提高生活质量。
